Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
The Union Minister reviewed DST-supported SATHI-BHU facility
Approval strengthens the company’s growing international anti-infective portfolio
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Subscribe To Our Newsletter & Stay Updated
